{
  "docId": "019de070-1001-704a-89ab-d7496f4fd716",
  "docSlug": "51e89351998d2fd4ac099e485858473c",
  "documentTitle": "BioNTech | Results Presentation Deck | 11 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2020-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 11,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "other",
  "function": "present_framework",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a visual representation of immune response over time to explain vaccine dosing strategies.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de070-1001-704a-89ab-d7496f4fd716/6",
  "deckHref": "/decks/019de070-1001-704a-89ab-d7496f4fd716",
  "deckJsonHref": "/decks/019de070-1001-704a-89ab-d7496f4fd716.json",
  "deckAnchorHref": "/decks/019de070-1001-704a-89ab-d7496f4fd716#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.45,
        "x": 0.04,
        "y": 0.78
      },
      "kind": "callout",
      "text": "First cohorts dosed in each geography. First clinical data expected June/July 2020",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b3ad2f02-3792-4393-bb93-e199ab455130",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.52,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Prime / boost vaccine immune response curve",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cbce48ba-50a6-4b2b-a407-6d94b9b3ef17",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.52,
        "y": 0.58
      },
      "kind": "chart",
      "text": "Prime-only vaccine immune response curve",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e35a242c-466d-4eba-89c9-3dc6e1d229ef",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.45,
        "x": 0.04,
        "y": 0.2
      },
      "kind": "list",
      "text": "Phase 1/2 trials ongoing in Europe and US: Testing of 4 vaccine candidates, evaluating safety/efficacy/dose, effects of repeated immunization, and accelerated approval pathways.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ddf4444-a197-4ce3-b06f-dc96a46f45ac",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.45,
        "x": 0.04,
        "y": 0.52
      },
      "kind": "list",
      "text": "Designs: Europe (dose escalation, 200 subjects), US (seamless design, 360 subjects), dose range 1-100ug, single/2-dose regimens.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "933114f6-8d68-4022-81a4-2633662001af",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "Global BNT162 clinical development program ongoing",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5ce339e5-a93c-4af6-b382-6ebd09781d54",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 5,
      "beatId": "70a870d9-8371-4d5d-a593-04abd08ac160",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "Slides 5-6 discuss the BNT162 mRNA vaccine program.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    },
    {
      "to": 10,
      "from": 4,
      "beatId": "a1e10f88-6e5d-473c-a25a-cabcc03d02ec",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Key Takeaways",
      "beatSlug": null,
      "evidence": "Slides 4 and 10 provide key takeaways on the COVID-19 program and building a next-generation immunotherapy company.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}